Cooperative effects in differentiation and proliferation between PDGF-BB and matrix derived synthetic peptides in human osteoblasts

BMC Musculoskeletal Disorders

Volumn 12, Issue , 2011, Pages

  Vordemvenne, Thomas ^a   Paletta, Jürgen Rj ^b   Hartensuer, Rene ^a   Pap, Thomas ^a   Raschke, Michael J ^a   Ochman, Sabine ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AC 100 PROTEIN; ALKALINE PHOSPHATE; COLLAGEN TYPE 1; COMPLEMENTARY DNA; OSTEOCALCIN; PHOSPHATE; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN P15; RUSALATIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; ANGIOGENIC FACTOR; CELL BINDING PEPTIDE P 15; CELL-BINDING PEPTIDE P-15; COLLAGEN; PEPTIDE FRAGMENT; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; SCLEROPROTEIN; THROMBIN;

ADULT; AGED; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; BONE MINERALIZATION; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FRACTURE HEALING; GENE EXPRESSION; HUMAN; HUMAN CELL; OSTEOBLAST; RNA EXTRACTION; CELL COMMUNICATION; CELL CULTURE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; MIDDLE AGED; PHYSIOLOGY; SYNTHESIS;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INDUCING AGENTS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MIDDLE AGED; OSTEOBLASTS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-SIS; THROMBIN;

EID: 81355138197     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-12-263     Document Type: Article

References (38)

1. Combination of bone marrow and TGF-beta1 augment the healing of critical-sized bone defects. Beck LS, Wong RL, DeGuzman L, Lee WP, Ongpipattanakul B, Nguyen TH, J Pharm Sci 1998 87 11 1379 1386
2. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Bostrom M, Lane JM, Tomin E, Browne M, Berberian W, Turek T, Smith J, Wozney J, Schildhauer T, Clin Orthop Relat Res 1996 327 272 282 (Pubitemid 26174996)
3. Effect of BMP-2 and BMP-7 homodimers and a mixture of BMP-2/BMP-7 homodimers on osteoblast adhesion and growth following culture on a collagen scaffold. Laflamme C, Rouabhia M, Biomed Mater 2008 3 1 015008
4. Enhancement of recombinant human BMP-7 bone formation with bmp binding peptide in a rodent femoral defect model. Liao J-C, Tzeng S-T, Keorochana G, Lee K-B, Johnson JS, Morishita Y, Murray SS, Wang JC, J Orthop Res 2011 29 5 753 759
5. Growth factors and the regulation of bone remodeling. Canalis E, McCarthy T, Centrella M, J Clin Invest 1988 81 2 277 281 (Pubitemid 18075217)
6. Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation-A study of immunocompromised mice. Ranly D, McMillan J, Keller T, Lohmann C, Meunch T, Cochran D, Schwartz Z, Boyan B, J Bone Joint Surg Am 2005 87A 9 2052 2064 (Pubitemid 41279137)
7. The PI 3-kinase isoforms p110(alpha) and p110(beta) have differential roles in PDGF- and insulin-mediated signaling. Vanhaesebroeck B, Claesson-Welsh L, J Cell Sci 2000 113 Pt 2 207 14 (Pubitemid 30088966)
8. Growth Factor Regulation of Fracture Repair. Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TA, J Bone Miner Res 1999 14 11 1805 1815 (Pubitemid 29521774)
9. Bone growth factors. Mohan S, Clin Orthop Relat Res 1991 263 30 48
10. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. Siegbahn A, Hammacher A, Westermark B, Heldin CH, J Clin Invest 1990 85 3 916 920 (Pubitemid 20087496)
11. Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. Park YJ, Lee YM, Lee JY, Seol YJ, Chung CP, Lee SJ, J Control Release 2000 67 2-3 385 394 (Pubitemid 30303850)
12. Controlled release of platelet-derived growth factor using ethylene vinyl acetate copolymer (EVAc) coated on stainless-steel wires. Walsh WR, Kim HD, Jong YS, Valentini RF, Biomaterials 1995 16 17 1319 1325
13. Collective review: bioactive implants coated with poly(D, L-lactide) and growth factors IGF-I, TGF-beta1, or BMP-2 for stimulation of fracture healing. Schmidmaier G, Lucke M, Schwabe P, Raschke M, Haas NP, Wildemann B, J Long Term Eff Med Implants 2006 16 1 61 69
14. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Schmidmaier G, Wildemann B, Bail H, Lucke M, Fuchs T, Stemberger A, Flyvbjerg A, Haas NP, Raschke M, Bone 2001 28 4 341 350 (Pubitemid 32390106)
15. A synthetic peptide fragment of human MEPE stimulates new bone formation in vitro and in vivo. Hayashibara T, Hiraga T, Yi B, Nomizu M, Kumagai Y, Nishimura R, Yoneda T, J Bone Miner Res 2004 19 3 455 462 (Pubitemid 38787401)
16. Dentonin, a MEPE fragment, initiates pulp-healing response to injury. Six N, Septier D, Chaussain-Miller C, Blacher R, DenBesten P, Goldberg M, J Dent Res 2007 86 8 780 785
17. Local injection of thrombin-related peptide (TP508) in PPF/PLGA microparticles-enhanced bone formation during distraction osteogenesis. Wang Y, Wan C, Szöke G, Ryaby JT, Li G, J Orthop Res 2008 26 4 539 546
18. Thrombin related peptide TP508 promoted fracture repair in a mouse high energy fracture model. Hanratty BM, Ryaby JT, Pan X-H, Li G, J Orthop Surg Res 2009 4 1
19. Thrombin peptide (TP508) promotes fracture repair by up-regulating inflammatory mediators, early growth factors, and increasing angiogenesis. Wang H, Li X, Tomin E, Doty SB, Lane JM, Carney DH, Ryaby JT, J Orthop Res 2005 23 3 671 679 (Pubitemid 40631341)
20. Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen. Qian JJ, Bhatnagar RS, J Biomed Mater Res 1996 31 4 545 54 (Pubitemid 26250999)
21. Enhanced cell attachment and osteoblastic activity by P-15 peptide-coated matrix in hydrogels. Nguyen H, Qian JJ, Bhatnagar RS, Li S, Biochem Biophys Res Commun 2003 311 1 179 86 (Pubitemid 37297904)
22. In vitro differentiation potential of a new human osteosarcoma cell line (HOS 58). Siggelkow H, Niedhart C, Kurre W, Ihbe A, Schulz A, Atkinson MJ, Hüfner M, Differentiation 1998 63 2 81 91 (Pubitemid 28301935)
23. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Martin I, Jakob M, Schäfer D, Dick W, Spagnoli G, Heberer M, Osteoarthritis Cartilage 2001 9 2 112 8 (Pubitemid 32229260)
24. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. Frank O, Heim M, Jakob M, Barbero A, Schäfer D, Bendik I, Dick W, Heberer M, Martin I, J Cell Biochem 2002 85 4 737 46 (Pubitemid 34462784)
25. rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508 induce chemotaxis of human osteoblasts and microvascular endothelial cells. Li G, Cui Y, McIlmurray L, Allen WE, Wang H, J Orthop Res 2005 23 3 680 685 (Pubitemid 40631342)
26. Growth and proliferation of human osteoblasts on different bone graft substitutes: an in vitro study. Kübler A, Neugebauer J, Oh J-H, Scheer M, Zöller JE, Implant Dent 2004 13 2 171 179 (Pubitemid 40340549)
27. Dentonin, a fragment of MEPE, enhanced dental pulp stem cell proliferation. Liu H, Li W, Gao C, Kumagai Y, Blacher RW, DenBesten PK, J Dent Res 2004 83 6 496 499 (Pubitemid 41756847)
28. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. Miyamoto S, Teramoto H, Gutkind JS, Yamada KM, J Cell Biol 1996 135 6 Pt 1 1633 1642 (Pubitemid 26427657)
29. The oligodendrocyte precursor mitogen PDGF stimulates proliferation by activation of alpha(v)beta3 integrins. Baron W, Shattil SJ, ffrench-Constant C, EMBO J 2002 21 8 1957 1966 (Pubitemid 34437193)
30. Growth factor modulation of fibroblasts in simulated wound healing. Bartold PM, Raben A, J Periodont Res 1996 31 3 205 216 (Pubitemid 126460205)
31. PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL. Getachew R, Ballinger ML, Burch ML, Reid JJ, Khachigian LM, Wight TN, Little PJ, Osman N, Endocrinology 2010 151 9 4356 4367
32. The role of proteoglycans in cell adhesion, migration and proliferation. Current opinion in cell biology. Wight T, Kinsella M, Curr Opin Cell Biol 1992 4 5 793 801
33. Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells. Kim SJ, Kim SY, Kwon CH, Kim YK, Growth Factors 2007 25 2 77 86 (Pubitemid 47487574)
34. Proliferating and differentiating effects of three different growth factors on pluripotent mesenchymal cells and osteoblast like cells. Wildemann B, Burkhardt N, Luebberstedt M, Vordemvenne T, Schmidmaier G, J Orthop Surg Res 2007 2 27
35. Differential growth factor control of bone formation through osteoprogenitor differentiation. Chaudhary LR, Hofmeister AM, Hruska KA, Bone 2004 34 3 402 411 (Pubitemid 38314905)
36. Temporal expression of PDGF receptors and PDGF regulatory effects on osteoblastic cells in mineralizing cultures. Yu X, Hsieh SC, Bao W, Graves DT, Am J Physiol 1997 272 5 Pt 1 1709 16
37. ERK pathways negatively regulate matrix mineralization. Kono S-J, Oshima Y, Hoshi K, Bonewald LF, Oda H, Nakamura K, Kawaguchi H, Tanaka S, Bone 2007 40 1 68 74 (Pubitemid 44839341)
38. Human osteoblasts synthesize and respond to platelet-derived growth factor. Zhang L, Leeman E, Carnes DC, Graves DT, Am J Physiol 1991 261 2 Pt 1 348 54